多価抗毒素のグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Polyvalent Antivenom Market Insights and Forecast to 2027

• レポートコード：QY2112C03911 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料は多価抗毒素の世界市場の現状について調査・分析し、2027年までの市場を予測しました。多価抗毒素の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（抗ウイルス毒素ベース抗毒素、抗神経毒抗毒素、抗混合毒抗毒素）、用途別市場規模（非営利団体、病院、クリニック）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・多価抗毒素の世界市場概要 ・メーカー別の競争状況、市場シェア ・多価抗毒素の種類別市場規模：抗ウイルス毒素ベース抗毒素、抗神経毒抗毒素、抗混合毒抗毒素 ・多価抗毒素の用途別市場規模：非営利団体、病院、クリニック ・北米の多価抗毒素市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパの多価抗毒素市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアの多価抗毒素市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米の多価抗毒素市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカの多価抗毒素市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：CSL、Merck、BTG、Pfizer、Haffkine Bio-Pharmaceutical、Rare Disease Therapeutics、Flynn Pharma、Vins Bioproducts、Bharat Serums and Vaccines、Serum Biotech、MicroPharm ・多価抗毒素のバリューチェーン・販売チャネル分析 ・多価抗毒素の世界市場動向

Snake antivenom is a medication made up of antibodies used to treat snake bites by venomous snakes. If the antivenom contains neutralizing antibodies raised against two or more species of snakes, then the composition is considered polyvalent.

Market Analysis and Insights: Global Polyvalent Antivenom Market
The global Polyvalent Antivenom market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Polyvalent Antivenom Scope and Segment
Polyvalent Antivenom market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Polyvalent Antivenom market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Antiviral Toxin-based Antivenom
Anti – Neurotoxic Antivenom
Anti – Mixed Venom Antivenom

Segment by Application
Non-profit Institutions
Hospitals and Clinic

By Company
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Polyvalent Antivenom Product Introduction
1.2 Market by Type
1.2.1 Global Polyvalent Antivenom Market Size Growth Rate by Type
1.2.2 Antiviral Toxin-based Antivenom
1.2.3 Anti – Neurotoxic Antivenom
1.2.4 Anti – Mixed Venom Antivenom
1.3 Market by Application
1.3.1 Global Polyvalent Antivenom Market Size Growth Rate by Application
1.3.2 Non-profit Institutions
1.3.3 Hospitals and Clinic
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Polyvalent Antivenom Sales Estimates and Forecasts 2016-2027
2.2 Global Polyvalent Antivenom Revenue Estimates and Forecasts 2016-2027
2.3 Global Polyvalent Antivenom Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Polyvalent Antivenom Regions by Sales
2.4.1 Global Top Polyvalent Antivenom Regions by Sales (2016-2021)
2.4.2 Global Top Polyvalent Antivenom Regions by Sales (2022-2027)
2.5 Global Top Polyvalent Antivenom Regions by Revenue
2.5.1 Global Top Polyvalent Antivenom Regions by Revenue (2016-2021)
2.5.2 Global Top Polyvalent Antivenom Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Polyvalent Antivenom Sales by Manufacturers
3.1.1 Global Top Polyvalent Antivenom Manufacturers by Sales (2016-2021)
3.1.2 Global Top Polyvalent Antivenom Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Polyvalent Antivenom Sales in 2020
3.2 Global Polyvalent Antivenom Revenue by Manufacturers
3.2.1 Global Top Polyvalent Antivenom Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Polyvalent Antivenom Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Polyvalent Antivenom Revenue in 2020
3.3 Global Polyvalent Antivenom Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Polyvalent Antivenom Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Polyvalent Antivenom Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Polyvalent Antivenom Sales by Type
4.1.1 Global Polyvalent Antivenom Historical Sales by Type (2016-2021)
4.1.2 Global Polyvalent Antivenom Forecasted Sales by Type (2022-2027)
4.1.3 Global Polyvalent Antivenom Sales Market Share by Type (2016-2027)
4.2 Global Polyvalent Antivenom Revenue by Type
4.2.1 Global Polyvalent Antivenom Historical Revenue by Type (2016-2021)
4.2.2 Global Polyvalent Antivenom Forecasted Revenue by Type (2022-2027)
4.2.3 Global Polyvalent Antivenom Revenue Market Share by Type (2016-2027)
4.3 Global Polyvalent Antivenom Price by Type
4.3.1 Global Polyvalent Antivenom Price by Type (2016-2021)
4.3.2 Global Polyvalent Antivenom Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Polyvalent Antivenom Sales by Application
5.1.1 Global Polyvalent Antivenom Historical Sales by Application (2016-2021)
5.1.2 Global Polyvalent Antivenom Forecasted Sales by Application (2022-2027)
5.1.3 Global Polyvalent Antivenom Sales Market Share by Application (2016-2027)
5.2 Global Polyvalent Antivenom Revenue by Application
5.2.1 Global Polyvalent Antivenom Historical Revenue by Application (2016-2021)
5.2.2 Global Polyvalent Antivenom Forecasted Revenue by Application (2022-2027)
5.2.3 Global Polyvalent Antivenom Revenue Market Share by Application (2016-2027)
5.3 Global Polyvalent Antivenom Price by Application
5.3.1 Global Polyvalent Antivenom Price by Application (2016-2021)
5.3.2 Global Polyvalent Antivenom Price Forecast by Application (2022-2027)

6 North America
6.1 North America Polyvalent Antivenom Market Size by Type
6.1.1 North America Polyvalent Antivenom Sales by Type (2016-2027)
6.1.2 North America Polyvalent Antivenom Revenue by Type (2016-2027)
6.2 North America Polyvalent Antivenom Market Size by Application
6.2.1 North America Polyvalent Antivenom Sales by Application (2016-2027)
6.2.2 North America Polyvalent Antivenom Revenue by Application (2016-2027)
6.3 North America Polyvalent Antivenom Market Size by Country
6.3.1 North America Polyvalent Antivenom Sales by Country (2016-2027)
6.3.2 North America Polyvalent Antivenom Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Polyvalent Antivenom Market Size by Type
7.1.1 Europe Polyvalent Antivenom Sales by Type (2016-2027)
7.1.2 Europe Polyvalent Antivenom Revenue by Type (2016-2027)
7.2 Europe Polyvalent Antivenom Market Size by Application
7.2.1 Europe Polyvalent Antivenom Sales by Application (2016-2027)
7.2.2 Europe Polyvalent Antivenom Revenue by Application (2016-2027)
7.3 Europe Polyvalent Antivenom Market Size by Country
7.3.1 Europe Polyvalent Antivenom Sales by Country (2016-2027)
7.3.2 Europe Polyvalent Antivenom Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Polyvalent Antivenom Market Size by Type
8.1.1 Asia Pacific Polyvalent Antivenom Sales by Type (2016-2027)
8.1.2 Asia Pacific Polyvalent Antivenom Revenue by Type (2016-2027)
8.2 Asia Pacific Polyvalent Antivenom Market Size by Application
8.2.1 Asia Pacific Polyvalent Antivenom Sales by Application (2016-2027)
8.2.2 Asia Pacific Polyvalent Antivenom Revenue by Application (2016-2027)
8.3 Asia Pacific Polyvalent Antivenom Market Size by Region
8.3.1 Asia Pacific Polyvalent Antivenom Sales by Region (2016-2027)
8.3.2 Asia Pacific Polyvalent Antivenom Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Polyvalent Antivenom Market Size by Type
9.1.1 Latin America Polyvalent Antivenom Sales by Type (2016-2027)
9.1.2 Latin America Polyvalent Antivenom Revenue by Type (2016-2027)
9.2 Latin America Polyvalent Antivenom Market Size by Application
9.2.1 Latin America Polyvalent Antivenom Sales by Application (2016-2027)
9.2.2 Latin America Polyvalent Antivenom Revenue by Application (2016-2027)
9.3 Latin America Polyvalent Antivenom Market Size by Country
9.3.1 Latin America Polyvalent Antivenom Sales by Country (2016-2027)
9.3.2 Latin America Polyvalent Antivenom Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Polyvalent Antivenom Market Size by Type
10.1.1 Middle East and Africa Polyvalent Antivenom Sales by Type (2016-2027)
10.1.2 Middle East and Africa Polyvalent Antivenom Revenue by Type (2016-2027)
10.2 Middle East and Africa Polyvalent Antivenom Market Size by Application
10.2.1 Middle East and Africa Polyvalent Antivenom Sales by Application (2016-2027)
10.2.2 Middle East and Africa Polyvalent Antivenom Revenue by Application (2016-2027)
10.3 Middle East and Africa Polyvalent Antivenom Market Size by Country
10.3.1 Middle East and Africa Polyvalent Antivenom Sales by Country (2016-2027)
10.3.2 Middle East and Africa Polyvalent Antivenom Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Overview
11.1.3 CSL Polyvalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 CSL Polyvalent Antivenom Product Description
11.1.5 CSL Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Polyvalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Merck Polyvalent Antivenom Product Description
11.2.5 Merck Recent Developments
11.3 BTG
11.3.1 BTG Corporation Information
11.3.2 BTG Overview
11.3.3 BTG Polyvalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 BTG Polyvalent Antivenom Product Description
11.3.5 BTG Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Polyvalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Pfizer Polyvalent Antivenom Product Description
11.4.5 Pfizer Recent Developments
11.5 Haffkine Bio-Pharmaceutical
11.5.1 Haffkine Bio-Pharmaceutical Corporation Information
11.5.2 Haffkine Bio-Pharmaceutical Overview
11.5.3 Haffkine Bio-Pharmaceutical Polyvalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Haffkine Bio-Pharmaceutical Polyvalent Antivenom Product Description
11.5.5 Haffkine Bio-Pharmaceutical Recent Developments
11.6 Rare Disease Therapeutics
11.6.1 Rare Disease Therapeutics Corporation Information
11.6.2 Rare Disease Therapeutics Overview
11.6.3 Rare Disease Therapeutics Polyvalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Rare Disease Therapeutics Polyvalent Antivenom Product Description
11.6.5 Rare Disease Therapeutics Recent Developments
11.7 Flynn Pharma
11.7.1 Flynn Pharma Corporation Information
11.7.2 Flynn Pharma Overview
11.7.3 Flynn Pharma Polyvalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Flynn Pharma Polyvalent Antivenom Product Description
11.7.5 Flynn Pharma Recent Developments
11.8 Vins Bioproducts
11.8.1 Vins Bioproducts Corporation Information
11.8.2 Vins Bioproducts Overview
11.8.3 Vins Bioproducts Polyvalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Vins Bioproducts Polyvalent Antivenom Product Description
11.8.5 Vins Bioproducts Recent Developments
11.9 Bharat Serums and Vaccines
11.9.1 Bharat Serums and Vaccines Corporation Information
11.9.2 Bharat Serums and Vaccines Overview
11.9.3 Bharat Serums and Vaccines Polyvalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Bharat Serums and Vaccines Polyvalent Antivenom Product Description
11.9.5 Bharat Serums and Vaccines Recent Developments
11.10 Serum Biotech
11.10.1 Serum Biotech Corporation Information
11.10.2 Serum Biotech Overview
11.10.3 Serum Biotech Polyvalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Serum Biotech Polyvalent Antivenom Product Description
11.10.5 Serum Biotech Recent Developments
11.11 MicroPharm
11.11.1 MicroPharm Corporation Information
11.11.2 MicroPharm Overview
11.11.3 MicroPharm Polyvalent Antivenom Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 MicroPharm Polyvalent Antivenom Product Description
11.11.5 MicroPharm Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Polyvalent Antivenom Value Chain Analysis
12.2 Polyvalent Antivenom Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Polyvalent Antivenom Production Mode & Process
12.4 Polyvalent Antivenom Sales and Marketing
12.4.1 Polyvalent Antivenom Sales Channels
12.4.2 Polyvalent Antivenom Distributors
12.5 Polyvalent Antivenom Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Polyvalent Antivenom Industry Trends
13.2 Polyvalent Antivenom Market Drivers
13.3 Polyvalent Antivenom Market Challenges
13.4 Polyvalent Antivenom Market Restraints

14 Key Findings in The Global Polyvalent Antivenom Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Polyvalent Antivenom Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Antiviral Toxin-based Antivenom
Table 3. Major Manufacturers of Anti - Neurotoxic Antivenom
Table 4. Major Manufacturers of Anti - Mixed Venom Antivenom
Table 5. Global Polyvalent Antivenom Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Polyvalent Antivenom Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Polyvalent Antivenom Sales by Region (2016-2021) & (K Units)
Table 8. Global Polyvalent Antivenom Sales Market Share by Region (2016-2021)
Table 9. Global Polyvalent Antivenom Sales by Region (2022-2027) & (K Units)
Table 10. Global Polyvalent Antivenom Sales Market Share by Region (2022-2027)
Table 11. Global Polyvalent Antivenom Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Polyvalent Antivenom Revenue Market Share by Region (2016-2021)
Table 13. Global Polyvalent Antivenom Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Polyvalent Antivenom Revenue Market Share by Region (2022-2027)
Table 15. Global Polyvalent Antivenom Sales by Manufacturers (2016-2021) & (K Units)
Table 16. Global Polyvalent Antivenom Sales Share by Manufacturers (2016-2021)
Table 17. Global Polyvalent Antivenom Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Polyvalent Antivenom Revenue Share by Manufacturers (2016-2021)
Table 19. Polyvalent Antivenom Price by Manufacturers 2016-2021 (US$/Unit)
Table 20. Global Polyvalent Antivenom Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Polyvalent Antivenom by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polyvalent Antivenom as of 2020)
Table 22. Polyvalent Antivenom Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Polyvalent Antivenom Product Offered
Table 24. Date of Manufacturers Enter into Polyvalent Antivenom Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Polyvalent Antivenom Sales by Type (2016-2021) & (K Units)
Table 27. Global Polyvalent Antivenom Sales by Type (2022-2027) & (K Units)
Table 28. Global Polyvalent Antivenom Sales Share by Type (2016-2021)
Table 29. Global Polyvalent Antivenom Sales Share by Type (2022-2027)
Table 30. Global Polyvalent Antivenom Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Polyvalent Antivenom Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Polyvalent Antivenom Revenue Share by Type (2016-2021)
Table 33. Global Polyvalent Antivenom Revenue Share by Type (2022-2027)
Table 34. Polyvalent Antivenom Price by Type (2016-2021) & (US$/Unit)
Table 35. Global Polyvalent Antivenom Price Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Polyvalent Antivenom Sales by Application (2016-2021) & (K Units)
Table 37. Global Polyvalent Antivenom Sales by Application (2022-2027) & (K Units)
Table 38. Global Polyvalent Antivenom Sales Share by Application (2016-2021)
Table 39. Global Polyvalent Antivenom Sales Share by Application (2022-2027)
Table 40. Global Polyvalent Antivenom Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Polyvalent Antivenom Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Polyvalent Antivenom Revenue Share by Application (2016-2021)
Table 43. Global Polyvalent Antivenom Revenue Share by Application (2022-2027)
Table 44. Polyvalent Antivenom Price by Application (2016-2021) & (US$/Unit)
Table 45. Global Polyvalent Antivenom Price Forecast by Application (2022-2027) & (US$/Unit)
Table 46. North America Polyvalent Antivenom Sales by Type (2016-2021) & (K Units)
Table 47. North America Polyvalent Antivenom Sales by Type (2022-2027) & (K Units)
Table 48. North America Polyvalent Antivenom Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Polyvalent Antivenom Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Polyvalent Antivenom Sales by Application (2016-2021) & (K Units)
Table 51. North America Polyvalent Antivenom Sales by Application (2022-2027) & (K Units)
Table 52. North America Polyvalent Antivenom Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Polyvalent Antivenom Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Polyvalent Antivenom Sales by Country (2016-2021) & (K Units)
Table 55. North America Polyvalent Antivenom Sales by Country (2022-2027) & (K Units)
Table 56. North America Polyvalent Antivenom Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Polyvalent Antivenom Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Polyvalent Antivenom Sales by Type (2016-2021) & (K Units)
Table 59. Europe Polyvalent Antivenom Sales by Type (2022-2027) & (K Units)
Table 60. Europe Polyvalent Antivenom Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Polyvalent Antivenom Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Polyvalent Antivenom Sales by Application (2016-2021) & (K Units)
Table 63. Europe Polyvalent Antivenom Sales by Application (2022-2027) & (K Units)
Table 64. Europe Polyvalent Antivenom Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Polyvalent Antivenom Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Polyvalent Antivenom Sales by Country (2016-2021) & (K Units)
Table 67. Europe Polyvalent Antivenom Sales by Country (2022-2027) & (K Units)
Table 68. Europe Polyvalent Antivenom Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Polyvalent Antivenom Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Polyvalent Antivenom Sales by Type (2016-2021) & (K Units)
Table 71. Asia Pacific Polyvalent Antivenom Sales by Type (2022-2027) & (K Units)
Table 72. Asia Pacific Polyvalent Antivenom Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Polyvalent Antivenom Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Polyvalent Antivenom Sales by Application (2016-2021) & (K Units)
Table 75. Asia Pacific Polyvalent Antivenom Sales by Application (2022-2027) & (K Units)
Table 76. Asia Pacific Polyvalent Antivenom Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Polyvalent Antivenom Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Polyvalent Antivenom Sales by Region (2016-2021) & (K Units)
Table 79. Asia Pacific Polyvalent Antivenom Sales by Region (2022-2027) & (K Units)
Table 80. Asia Pacific Polyvalent Antivenom Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Polyvalent Antivenom Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Polyvalent Antivenom Sales by Type (2016-2021) & (K Units)
Table 83. Latin America Polyvalent Antivenom Sales by Type (2022-2027) & (K Units)
Table 84. Latin America Polyvalent Antivenom Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Polyvalent Antivenom Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Polyvalent Antivenom Sales by Application (2016-2021) & (K Units)
Table 87. Latin America Polyvalent Antivenom Sales by Application (2022-2027) & (K Units)
Table 88. Latin America Polyvalent Antivenom Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Polyvalent Antivenom Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Polyvalent Antivenom Sales by Country (2016-2021) & (K Units)
Table 91. Latin America Polyvalent Antivenom Sales by Country (2022-2027) & (K Units)
Table 92. Latin America Polyvalent Antivenom Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Polyvalent Antivenom Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Polyvalent Antivenom Sales by Type (2016-2021) & (K Units)
Table 95. Middle East and Africa Polyvalent Antivenom Sales by Type (2022-2027) & (K Units)
Table 96. Middle East and Africa Polyvalent Antivenom Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Polyvalent Antivenom Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Polyvalent Antivenom Sales by Application (2016-2021) & (K Units)
Table 99. Middle East and Africa Polyvalent Antivenom Sales by Application (2022-2027) & (K Units)
Table 100. Middle East and Africa Polyvalent Antivenom Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Polyvalent Antivenom Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Polyvalent Antivenom Sales by Country (2016-2021) & (K Units)
Table 103. Middle East and Africa Polyvalent Antivenom Sales by Country (2022-2027) & (K Units)
Table 104. Middle East and Africa Polyvalent Antivenom Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Polyvalent Antivenom Revenue by Country (2022-2027) & (US$ Million)
Table 106. CSL Corporation Information
Table 107. CSL Description and Major Businesses
Table 108. CSL Polyvalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 109. CSL Polyvalent Antivenom Product
Table 110. CSL Recent Developments
Table 111. Merck Corporation Information
Table 112. Merck Description and Major Businesses
Table 113. Merck Polyvalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 114. Merck Polyvalent Antivenom Product
Table 115. Merck Recent Developments
Table 116. BTG Corporation Information
Table 117. BTG Description and Major Businesses
Table 118. BTG Polyvalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 119. BTG Polyvalent Antivenom Product
Table 120. BTG Recent Developments
Table 121. Pfizer Corporation Information
Table 122. Pfizer Description and Major Businesses
Table 123. Pfizer Polyvalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 124. Pfizer Polyvalent Antivenom Product
Table 125. Pfizer Recent Developments
Table 126. Haffkine Bio-Pharmaceutical Corporation Information
Table 127. Haffkine Bio-Pharmaceutical Description and Major Businesses
Table 128. Haffkine Bio-Pharmaceutical Polyvalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 129. Haffkine Bio-Pharmaceutical Polyvalent Antivenom Product
Table 130. Haffkine Bio-Pharmaceutical Recent Developments
Table 131. Rare Disease Therapeutics Corporation Information
Table 132. Rare Disease Therapeutics Description and Major Businesses
Table 133. Rare Disease Therapeutics Polyvalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 134. Rare Disease Therapeutics Polyvalent Antivenom Product
Table 135. Rare Disease Therapeutics Recent Developments
Table 136. Flynn Pharma Corporation Information
Table 137. Flynn Pharma Description and Major Businesses
Table 138. Flynn Pharma Polyvalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 139. Flynn Pharma Polyvalent Antivenom Product
Table 140. Flynn Pharma Recent Developments
Table 141. Vins Bioproducts Corporation Information
Table 142. Vins Bioproducts Description and Major Businesses
Table 143. Vins Bioproducts Polyvalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 144. Vins Bioproducts Polyvalent Antivenom Product
Table 145. Vins Bioproducts Recent Developments
Table 146. Bharat Serums and Vaccines Corporation Information
Table 147. Bharat Serums and Vaccines Description and Major Businesses
Table 148. Bharat Serums and Vaccines Polyvalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 149. Bharat Serums and Vaccines Polyvalent Antivenom Product
Table 150. Bharat Serums and Vaccines Recent Developments
Table 151. Serum Biotech Corporation Information
Table 152. Serum Biotech Description and Major Businesses
Table 153. Serum Biotech Polyvalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 154. Serum Biotech Polyvalent Antivenom Product
Table 155. Serum Biotech Recent Developments
Table 156. MicroPharm Corporation Information
Table 157. MicroPharm Description and Major Businesses
Table 158. MicroPharm Polyvalent Antivenom Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 159. MicroPharm Polyvalent Antivenom Product
Table 160. MicroPharm Recent Developments
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Polyvalent Antivenom Distributors List
Table 164. Polyvalent Antivenom Customers List
Table 165. Polyvalent Antivenom Market Trends
Table 166. Polyvalent Antivenom Market Drivers
Table 167. Polyvalent Antivenom Market Challenges
Table 168. Polyvalent Antivenom Market Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Polyvalent Antivenom Product Picture
Figure 2. Global Polyvalent Antivenom Market Share by Type in 2020 & 2027
Figure 3. Antiviral Toxin-based Antivenom Product Picture
Figure 4. Anti - Neurotoxic Antivenom Product Picture
Figure 5. Anti - Mixed Venom Antivenom Product Picture
Figure 6. Global Polyvalent Antivenom Market Share by Application in 2020 & 2027
Figure 7. Non-profit Institutions
Figure 8. Hospitals and Clinic
Figure 9. Polyvalent Antivenom Report Years Considered
Figure 10. Global Polyvalent Antivenom Sales 2016-2027 (K Units)
Figure 11. Global Polyvalent Antivenom Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Polyvalent Antivenom Revenue 2016-2027 (US$ Million)
Figure 13. Global Polyvalent Antivenom Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Polyvalent Antivenom Sales Market Share by Region (2016-2021)
Figure 15. Global Polyvalent Antivenom Sales Market Share by Region (2022-2027)
Figure 16. North America Polyvalent Antivenom Sales YoY (2016-2027) & (K Units)
Figure 17. North America Polyvalent Antivenom Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Polyvalent Antivenom Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Polyvalent Antivenom Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Polyvalent Antivenom Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Polyvalent Antivenom Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Polyvalent Antivenom Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Polyvalent Antivenom Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Polyvalent Antivenom Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Polyvalent Antivenom Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Polyvalent Antivenom Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Polyvalent Antivenom Revenue in 2020
Figure 28. Polyvalent Antivenom Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Polyvalent Antivenom Sales Market Share by Type (2016-2027)
Figure 30. Global Polyvalent Antivenom Revenue Market Share by Type (2016-2027)
Figure 31. Global Polyvalent Antivenom Sales Market Share by Application (2016-2027)
Figure 32. Global Polyvalent Antivenom Revenue Market Share by Application (2016-2027)
Figure 33. North America Polyvalent Antivenom Sales Market Share by Type (2016-2027)
Figure 34. North America Polyvalent Antivenom Revenue Market Share by Type (2016-2027)
Figure 35. North America Polyvalent Antivenom Sales Market Share by Application (2016-2027)
Figure 36. North America Polyvalent Antivenom Revenue Market Share by Application (2016-2027)
Figure 37. North America Polyvalent Antivenom Sales Share by Country (2016-2027)
Figure 38. North America Polyvalent Antivenom Revenue Share by Country (2016-2027)
Figure 39. United States Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Polyvalent Antivenom Sales Market Share by Type (2016-2027)
Figure 42. Europe Polyvalent Antivenom Revenue Market Share by Type (2016-2027)
Figure 43. Europe Polyvalent Antivenom Sales Market Share by Application (2016-2027)
Figure 44. Europe Polyvalent Antivenom Revenue Market Share by Application (2016-2027)
Figure 45. Europe Polyvalent Antivenom Sales Share by Country (2016-2027)
Figure 46. Europe Polyvalent Antivenom Revenue Share by Country (2016-2027)
Figure 47. Germany Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 48. France Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Polyvalent Antivenom Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Polyvalent Antivenom Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Polyvalent Antivenom Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Polyvalent Antivenom Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Polyvalent Antivenom Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Polyvalent Antivenom Revenue Share by Region (2016-2027)
Figure 58. China Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 61. India Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 63. Taiwan Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Polyvalent Antivenom Sales Market Share by Type (2016-2027)
Figure 68. Latin America Polyvalent Antivenom Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Polyvalent Antivenom Sales Market Share by Application (2016-2027)
Figure 70. Latin America Polyvalent Antivenom Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Polyvalent Antivenom Sales Share by Country (2016-2027)
Figure 72. Latin America Polyvalent Antivenom Revenue Share by Country (2016-2027)
Figure 73. Mexico Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 76. Middle East and Africa Polyvalent Antivenom Sales Market Share by Type (2016-2027)
Figure 77. Middle East and Africa Polyvalent Antivenom Revenue Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Polyvalent Antivenom Sales Market Share by Application (2016-2027)
Figure 79. Middle East and Africa Polyvalent Antivenom Revenue Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Polyvalent Antivenom Sales Share by Country (2016-2027)
Figure 81. Middle East and Africa Polyvalent Antivenom Revenue Share by Country (2016-2027)
Figure 82. Turkey Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 83. Saudi Arabia Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 84. UAE Polyvalent Antivenom Revenue (2016-2027) & (US$ Million)
Figure 85. Polyvalent Antivenom Value Chain
Figure 86. Polyvalent Antivenom Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

---